381
Views
3
CrossRef citations to date
0
Altmetric
Review

Subcutaneous tocilizumab: recent advances for the treatment of rheumatoid arthritis

ORCID Icon, ORCID Icon, &
Pages 639-648 | Received 23 Feb 2019, Accepted 10 May 2019, Published online: 05 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Masataka Torigoe, Keisuke Maeshima, Yuhei Kuriyama, Itomi Abe, Takashi Ozaki, Yuichi Omura, Tatsuhito Umeki, Chiharu Imada, Koji Ishii & Hirotaka Shibata. (2021) Effectiveness of subcutaneous tocilizumab in refractory adult Still’s disease: report of three cases and a review of the literature. Modern Rheumatology Case Reports 5:2, pages 365-370.
Read now

Articles from other publishers (2)

Aubin Pitiot, Nathalie Heuzé-Vourc’h & Thomas Sécher. (2022) Alternative Routes of Administration for Therapeutic Antibodies—State of the Art. Antibodies 11:3, pages 56.
Crossref
Nuray Aktay Ayaz, Şerife Gül Karadağ, Rahime Koç, Fatma Gül Demirkan, Figen Çakmak & Hafize Emine Sönmez. (2020) Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study. Rheumatology International 40:7, pages 1111-1116.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.